Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 1, 1996, Pages 27-29

  Rezza, Giovanni ^a   Sagliocca, Luciano ^b   Zaccarelli, Mauro ^a   Nespoli, Matteo ^b   Siconolfi, Marina ^c   Baldassarre, Clara ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Regional Epidemiological Unit (OER)   (Italy)

^c Drug Treatment Centre (SERT USL 38)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHADONE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; ITALY; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK FACTOR; SEROCONVERSION;

EID: 0029923036     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027145     Document Type: Article

References (16)

1. Rezza G. Regional variations in HIV seroprevalence among injecting drug users in Italy. Rec Epidem Santé Publ 38: 263-264, 1990.
2. Rezza G, Nicolosi A, Zacearelli M, Sagliocca L, Nespoli M, Gattari P, Spizzichino L, Ippolito G. Lazzarin A. J Acquired Immune Deficiency Syndrome 7: 500-503, 1994.
3. Patti AM, Santi AL, Pompa MG, Giustini C, Vescia N, Mastroeni I, Fara GM. Viral hepatitis and drugs: a continuing problem. Int J Epidemiol 22: 135-139, 1993.
4. Gabrielli C, Zannini A, Corradini R, Gafa S. Spread of intravenous drug users. J Infect 29: 17-22, 1994.
5. Guadagnino V, Zimatore G, Rocca A, Montesano F, Masciari R, Caroleo B, Izzi A, Morabito D, Naso E, Scicchitano R. Anti-hepatitis C antibody prevalence among intravenous drug addicts in the Catanzaro area. Arch Virol Suppl 4: 335-336, 1992.
6. Cacopardo B, Fatuzzo F, Cosentino S, Celesia BM, Mughini MT, La Rosa R, Bruno S, Lupo G, Zipper F, La Medica G. HCV and HIV infection among intravenous drug abusers in eastern Sicily. Arch Virol Suppl 4: 333-334, 1992.
7. Biancolilli V, D'Alessio G, Pennino G, D'Argenio P, Sagliocca L, Rezza G, Prevalenza e incidenza di infezione da HIV e virus epatitici fra i tossicodipendenti di Benevento: 1986-91. I1 Giornale Italiano dell'AIDS 3: 221-223, 1992.
8. Lanphear BP, Linnemann CC, Cannon CG, DeRonde MM, Pendy L, Kerley LM. Hepatitis C virus infection in health care workers: risk of exposure and infection Infect Contr Hosp Epidemiol 15: 745-750, 1994.
9. Henderson DK, Saah AJ, Zak BJ, Kaslow RA, Lane HC, Folks T, Blackwelder WC, Schmitt J, LaCamera DJ, Masur H. Risk of nosocomial infection with HTLV III/LAV in a large cohort of intensively exposed health care workers. Ann Intern Med 104: 644-647, 1986.
10. van der Poel C, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 344: 1475-1479, 1994.
11. Girardi E, Zaccarelli M, Tossini G, Puro V, Narciso P, Visco G Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis 22: 751-752, 1990.
12. Solomon L, Astemborski J, Warren D, Munoz A, Cohon S, Vlahov D, Nelson KE. Differences in risk factors for Human Immunodeficiency Virus Type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol 137: 892-898, 1993
13. Nicolosi A, Correa Leite ML, Musicco M, Molinari S, Lazzarin A. Parenteral and sexual transmission of human immunodeficiency virus: a study of seroconversion. Am J Epidemiol 135: 225-233, 1992.
14. Rezza G, Rota MC, Buning E, Hausser D, O'Hare P, Power R. Assessing HIV prevention among injecting drug users in European Community countries: a review. Soz Praventivmed 37 Suppl 1: S61-S78, 1994.
15. Serpelloni G, Carrieri MP, Rezza G, Morganti S, Gomma M, Binkin N. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care 6: 215-220, 1994.
16. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV-1 infection risk behaviors among intravenous drug users. Addiction 88: 517-526, 1993